Raising Funds for Growth Investments Through a Third-Party Allotment of Stock Acquisition Rights
First written in FY2021-Q2. 5 of 7 entries say "Advanced", first in FY2021-Q3. Latest entry: FY2022.
The whole theme swung hardest in 2025: 2 of 24 companies on the "Worse" side.
18 other companies' latest entry also says "Achieved".
- FY2022AchievedAnnual report
「Number of the relevant convertible bonds with stock acquisition rights and other instruments with exercise price adjustment provisions exercised during the period (units) 12,700 Shares delivered upon exercise during the period (shares) 1,270,000 Funds raised through exercises during the period (¥ million) 2,853 Cumulative number exercised as of the end of the period (units) 30,000 Cumulative shares delivered as of the end of the period (shares) 3,000,000 Cumulative funds raised as of the end of the period (¥ million) 7,624」
All 30,000 of the third series of stock acquisition rights were exercised, 3,000,000 shares were issued and cumulative funds raised totaled ¥7,624 million. As of 31 March 2022, no stock acquisition rights remained outstanding, completing the fundraising plan. - FY2022-Q3AdvancedAnnual report
「Net assets for the nine-month period of the current consolidated fiscal year amounted to ¥41,976 million, an increase of ¥5,773 million from the end of the previous consolidated fiscal year. This reflected increases of ¥1,431 million each in share capital and capital surplus from the payment for the third-party allotment, quarterly net income attributable to owners of the parent of ¥3,200 million, and the payment of dividends of ¥860 million, among other factors.」
The payment for the third-party allotment increased share capital and capital surplus by ¥1,431 million each, and the funds raised for growth investment are also reflected in the financial statements. - FY2022-Q2AdvancedAnnual report
「During the second-quarter accounting period, the stock acquisition rights attached to the relevant convertible bonds with stock acquisition rights and other instruments with exercise price adjustment provisions were exercised as follows. Number exercised during the second-quarter accounting period (units): 1,800; shares delivered upon exercise during the quarter (shares): 180,000; funds raised through exercises during the quarter (¥ million): 421. Cumulative number exercised as of the end of the quarter (units): 30,000; cumulative shares delivered as of the end of the quarter (shares): 3,000,000; cumulative funds raised as of the end of the quarter (¥ million): 7,624.」
During the second quarter, 1,800 of the third series of stock acquisition rights were exercised, raising ¥421 million. Cumulatively, 30,000 rights had been exercised, and funds raised totaled ¥7.624 billion. - FY2022-Q1AdvancedAnnual report
「Number of the relevant convertible bonds with stock acquisition rights and other instruments with exercise price adjustment provisions exercised during the quarter (units) 10,900 Number of shares delivered upon exercise during the quarter (shares) 1,090,000 Funds raised through exercises during the quarter (¥ million) 2,432 Cumulative number of the relevant convertible bonds with stock acquisition rights and other instruments with exercise price adjustment provisions exercised as of the end of the quarter (units) 28,200 Cumulative funds raised through the relevant convertible bonds with stock acquisition rights and other instruments with exercise price adjustment provisions as of the end of the quarter (¥ million) 7,203」
During the first quarter, 10,900 of the third series of stock acquisition rights were exercised, 1,090,000 shares were issued and ¥2.432 billion was raised. Cumulative funds raised reached ¥7.203 billion, representing further progress in raising funds for growth investment. - FY2021AdvancedAnnual report
「Funds raised through exercises during the period (¥ million) 3,052 4,770」
During FY2021, 1,730,000 shares were issued through the exercise of the third series of stock acquisition rights issued through a third-party allotment, raising ¥4.77 billion. The raising of funds for growth investment has moved into the execution stage. - FY2021-Q3AdvancedAnnual report
「Number of shares delivered upon exercise during the third-quarter accounting period (shares): 670,000 Average exercise price and other information relating to exercises during the third-quarter accounting period (yen): 2,564.34 Funds raised through exercises during the third-quarter accounting period (¥ million): 1,718」
During the third-quarter accounting period, 6,700 of the third series of stock acquisition rights issued through a third-party allotment were exercised, 670,000 shares were delivered and ¥1.718 billion was raised. The plan to raise funds for growth investment has moved into the execution stage. - FY2021-Q2First statedAnnual report
「At a meeting of the Board of Directors held on 10 November 2020, the company resolved to issue the third series of stock acquisition rights through a third-party allotment (the “Stock Acquisition Rights”).」
The company disclosed for the first time a plan to issue 30,000 stock acquisition rights through a third-party allotment and raise approximately ¥8.2 billion at maximum. The proceeds are to be allocated to establishing new production lines for the CTC business, capital investment in the MD business, and basic research and development in fine precision, high-frequency and smart production processes. The exercise period is from 3 December 2020 to 2 December 2022.